Reason for request
Réévaluation du niveau d'ASMR
Clinical Added Value
minor |
Velcade apporte une ASMR mineure (niveau IV) par rapport à la dexaméthasone dans le cadre du traitement du myélome multiple en deuxième ligne.
|
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
auPKR80t2BELZpd5